Lobbying registration dated 2026-02-23
Registrant: Richard Maksymetz
Client: Vimy Pharmaceuticals Inc.
Targeted institutions:
Prime Minister's Office (PMO)
House of Commons
Veterans Affairs Canada (VAC)
Innovation, Science and Economic Development Canada (ISED)
Indigenous Services Canada (ISC)
Federal Economic Development Agency for Southern Ontario (FedDev)
Privy Council Office (PCO)
Health Canada (HC)
Government funding received:
Lobbying activity details:
Communicating with government officials regarding regulatory requirements for the domestic manufacturing and market entry of generic semaglutide in Canada.